By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Australian genetics testing firm Genetic Technologies today said today it has executed an amendment to the Non-Coding License Agreement issued to Quest Diagnostics in 2003.

The amendment extends the terms of the Quest's original non-coding license to "regularize Quest's historical" worldwide activities related to its genetic diagnostic and analysis products. Terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The NIH has issued a preliminary guidance for newborn dried blood spot research.

Wired writes that CRISPR could change the world — in many imaginative ways — and whether it will be for the better is still in the air.

In PLOS this week: locus linked to non-syndromic hearing loss, phylogenetic relationships of Klebsiella pneumoniae isolates, and more.

In a column at Nature, researcher Fyodor Kondrashov worries about the influence of politics on Russian science.